Publication:
Characterization of Potential Antigenic Triggers and Self-Reactive Lymphocytes in IgG4-Related Disease

No Thumbnail Available

Date

2024-06-04

Published Version

Published Version

Journal Title

Journal ISSN

Volume Title

Publisher

The Harvard community has made this article openly available. Please share how this access benefits you.

Research Projects

Organizational Units

Journal Issue

Citation

Zhang, Zhenrui. 2024. Characterization of Potential Antigenic Triggers and Self-Reactive Lymphocytes in IgG4-Related Disease. Master's thesis, Harvard Medical School.

Research Data

Abstract

IgG4-related disease (IgG4-RD) is a chronic, inflammatory and fibrotic condition of suspected autoimmune etiology. The aim of this work is to explore the disease mechanism of IgG4-RD, focusing on identifying potential antigenic triggers and profiling self-reactive lymphocytes. Using assays based on the autoantibody profiles of IgG4-RD patients, several potential B cell antigens were identified, including ANXA11, AP1B1, FAM84A, and TBC1D25. Moreover, high anti-ANXA11 titer was shown to associate with increased pancreas and prostate involvement, while high anti-FAM84A reactivity was shown to associate with lacrimal and parotid gland involvement (i.e. Mikulicz phenotype). On the other hand, an activation assay was improved to better capture antigen-specific CD4+ T cell responses using COVID-19 patients’ PBMCs and SARS-CoV-2 spike protein peptides as a tool for the future validation of potential antigenic triggers in IgG4-RD from the T cell perspective. Finally, flow cytometry was used to phenotype potential self-reactive lymphocytes in IgG4-RD as part of a longitudinal clinical study. The long-term goal of this work is to use IgG4-RD as a prototype of systemic autoimmune conditions to better understand tolerance mechanisms and the break of tolerance in humans.

Description

Other Available Sources

Keywords

Immunology

Terms of Use

This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service

Endorsement

Review

Supplemented By

Referenced By

Related Stories